Chromane amidine monobactam compounds for the treatment of bacterial infections
US11932637B2 · kind B2 · utility
0Cited by
4References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2022 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | Nov 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to monobactam compounds of Formula I: and pharmaceutically acceptable salts thereof. The present invention also relates to compositions which comprise a monobactam compound of structural formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The invention further relates to methods for treating a bacterial infection comprising administering to the patient a therapeutically effective amount of a compound of structural formula I, either alone or in combination with a therapeutically effective amount of a second beta-lactam antibiotic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.